Targeting PAR-2-driven Inflammatory Pathways in Colorectal Cancer: Mechanistic Insights from Atorvastatin and Rosuvastatin Treatment in Cell Line Models.

Rajashree Patnaik, Riah Lee Varghese, Sara Khan, Bintul Huda, Farida Bhurka, Layla Amiri,Yajnavalka Banerjee

Translational cancer research（2025）

引用 0|浏览0